Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
These include diseases such as: Cirrhosis (severe scarring of the liver), Hepatitis B or C (viral infections that cause liver inflammation), Non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH)
They can help to protect the liver from damage, promote the regeneration of liver cells, and improve liver function
That could include hypertension, Type 2 diabetes, dyslipidemia (an imbalance of lipids such as cholesterol or triglycerides) and obstructive sleep apnea
.webp)
